What is EHRA type 1?
EHRA type 1 is defined as valvular heart disease (VHD) atrial fibrillation (AF) patients who need therapy with a vitamin K antagonist (VKA). It includes moderate to severe rheumatic mitral stenosis, mechanical prosthetic valve replacement, mitral regurgitation, mitral valve repair, aortic stenosis, aortic regurgitation, tricuspid regurgitation, tricuspid stenosis, pulmonary regurgitation, pulmonic stenosis, bioprosthetic valve replacements, and trans-aortic valve interventions.